LncRNA GATA6-AS inhibits cancer cell proliferation and promotes cancer cell apoptosis in cervical cancer by down-regulating miR-205

Abstract Background Dysregulated endothelial cell growth is involved in many types of human cancer, including cervical cancer. LncRNA GATA6-AS was reported to regulate endothelial cell growth, suggesting it might involve in cervical cancer. Our study was carried out to explore the involvement of GAT...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoying Zhao (Author), Huzhong Zheng (Author), Jun Chen (Author)
Format: Book
Published: BMC, 2020-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a1e08edbc3d64ae68dfa63d38e522f3a
042 |a dc 
100 1 0 |a Xiaoying Zhao  |e author 
700 1 0 |a Huzhong Zheng  |e author 
700 1 0 |a Jun Chen  |e author 
245 0 0 |a LncRNA GATA6-AS inhibits cancer cell proliferation and promotes cancer cell apoptosis in cervical cancer by down-regulating miR-205 
260 |b BMC,   |c 2020-11-01T00:00:00Z. 
500 |a 10.1186/s12905-020-01082-7 
500 |a 1472-6874 
520 |a Abstract Background Dysregulated endothelial cell growth is involved in many types of human cancer, including cervical cancer. LncRNA GATA6-AS was reported to regulate endothelial cell growth, suggesting it might involve in cervical cancer. Our study was carried out to explore the involvement of GATA6-AS in cervical squamous cell carcinoma (CSCC), a subtype of cervical cancer. Methods To explore the expression of GATA6-AS, RT-qPCR was performed to detect GATA6-AS in plasma of 65 CSCC patients and 58 healthy females. To detect the expression of GATA6-AS, total RNAs were extracted. Results We found that plasma GATA6-AS expression was down-regulated in CSCC patients than that in healthy females, and HPV infection did not significantly affect the plasma expression of GATA6-AS. Moreover, we found that plasma GATA6-AS showed diagnostic values for CSCC by performing ROC curve analysis. The expression of miR-205 in plasma was also found to be up-regulated in CSCC patients than that in healthy females and inversely correlated with the expression of GATA6-AS in CSCC patients. Furthermore, over-expression of miR-205 did not significantly affect the expression of GATA6-AS in CSCC cells, while over-expression of GATA6-AS down-regulated miR-205 expression. In addition, GATA6-AS over-expression inhibited CSCC cell proliferation and promoted CSCC cell apoptosis, while miR-205 over-expression played opposite roles and attenuated the effects of GATA6-AS over-expression on CSCC cells. Conclusion Taken together, these results suggest that GATA6-AS may inhibit cell proliferation and promote cell apoptosis in CSCC by down-regulating miR-205. 
546 |a EN 
690 |a CSCC 
690 |a GATA6-AS 
690 |a miR-205 
690 |a Proliferation 
690 |a Apoptosis 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n BMC Women's Health, Vol 20, Iss 1, Pp 1-6 (2020) 
787 0 |n http://link.springer.com/article/10.1186/s12905-020-01082-7 
787 0 |n https://doaj.org/toc/1472-6874 
856 4 1 |u https://doaj.org/article/a1e08edbc3d64ae68dfa63d38e522f3a  |z Connect to this object online.